Mor George Adi
Mor George Adi, CEO, reported an open-market or private purchase at Chemomab Therapeutics Ltd. involving 4878.000000 shares. Reported holdings after the transaction were 134205.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- May 29, 2026
- Filing date
- Jun 01, 2026
How reported position traded is calculated
Shares purchased ÷ (holdings after − shares purchased). Estimated position before: 129,327 shares.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
Filing warnings
Notes recorded with this filingCMMB price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- Buy Code P
- Identifier
- 0001178913-26-003004 American Depositary Shares
- Transaction date
- May 29, 2026 Filed Jun 01, 2026, 11:33 AM · 3d delay
- Shares
- 4,878 sh Price unknown
- Estimated value
- — Computed from shares × price
- Holdings after
- 134,205 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
+22 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.
How this score is calculated
- open_market_purchase+12 points
transaction_code = P
Code P is a discretionary open-market purchase. - direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - ceo_buy+12 points
is_officer + officer_title/role mentions CEO
CEO open-market purchase. - missing_price-8 points
price_cents is null
Missing price reduces confidence in value-based signals.
- price_cents
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
Chief Executive Officer
- F1
No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.
- F2
The American Depositary Shares reported in this row consist of restricted share units ("RSUs") that were granted to the Reporting Person by the Issuer on November 18, 2024, and vest and become exercis…
- F3
The American Depositary Shares reported in this row consist of RSUs that were granted to the Reporting Person by the Issuer on July 1, 2025 vest and become exercisable according to following schedule:…
0 other transactions
0 recent txs